{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:39:59Z","timestamp":1787063999983,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.msard.2018.12.038","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T20:36:34Z","timestamp":1546461394000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder"],"prefix":"10.1016","volume":"28","author":[{"given":"Yifan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanggui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Kermode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2018.12.038_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"9 Suppl 2","key":"10.1016\/j.msard.2018.12.038_bib0002","first-page":"S59","article-title":"Neuromyelitis optica spectrum disorders in children and adolescents","volume":"87","author":"Tenembaum","year":"2016","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2018.12.038_bib0003","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.0b013e3181f39a66","article-title":"Long-term follow-up of neuromyelitis optica with a paediatric onset","volume":"75","author":"Collongues","year":"2010","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.msard.2018.12.038_bib0004","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1212\/WNL.0b013e3181fc2823","article-title":"Neuromyelitis optica and NMO-IgG in European paediatric patients","volume":"75","author":"Huppke","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2018.12.038_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3928\/0191-3913-19960901-05","article-title":"paediatric Devic's neuromyelitis optica","volume":"33","author":"Jeffery","year":"1996","journal-title":"J. Pediatr Ophthalmol Strabismus"},{"issue":"3","key":"10.1016\/j.msard.2018.12.038_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0000000000002283","article-title":"Clinical features of neuromyelitis optica in children: US Network of paediatric MS centers report","volume":"86","author":"Chitnis","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2018.12.038_bib0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"Mckeon","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.msard.2018.12.038_bib0008","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2018.12.038_bib0009","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.msard.2018.12.038_bib0010","doi-asserted-by":"crossref","first-page":"e1039","DOI":"10.1542\/peds.2007-2758","article-title":"Spectrum of paediatric neuromyelitis optica","volume":"122","author":"Lotze","year":"2008","journal-title":"Paediatrics."},{"issue":"1","key":"10.1016\/j.msard.2018.12.038_bib0011","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2013.07.003","article-title":"Neuromyelitis optica with onset in childhood and adolescence","volume":"50","author":"Fragoso","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2018.12.038_bib0012","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.0000000000004312","article-title":"Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome","volume":"89","author":"Hennes","year":"2017","journal-title":"Neurology"},{"issue":"19","key":"10.1016\/j.msard.2018.12.038_bib0013","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1212\/WNL.0000000000003318","article-title":"A nationwide survey of paediatric acquired demyelinating syndromes in Japan","volume":"87","author":"Yamaguchi","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2018.12.038_bib0014","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2015-311743","article-title":"Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease","volume":"87","author":"Lechner","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2018.12.038_bib0015","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1212\/NXI.0000000000000062","article-title":"Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?","volume":"2","author":"Zamvil","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.msard.2018.12.038_bib0016","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2018.12.038_bib0017","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes.","author":"Zhou","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2018.12.038_bib0018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2018.12.038_bib0019","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","article-title":"Comparison of relapse and treatment failure rates among patients with neuromyelitis optica multicenter study of treatment efficacy","volume":"71","author":"Mealy","year":"2014","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.msard.2018.12.038_bib0020","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jocn.2015.01.028","article-title":"Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica","volume":"22","author":"Qiu","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"Pt 6","key":"10.1016\/j.msard.2018.12.038_bib0021","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.msard.2018.12.038_bib0022","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination: comparison between onset phenotypes","author":"Zhou","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2018.12.038_bib0023","doi-asserted-by":"crossref","first-page":"e225","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sepulveda","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.msard.2018.12.038_bib0024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.msard.2018.12.038_bib0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1177\/1352458512470310","article-title":"Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative paediatric neuromyelitis optica","volume":"19","author":"Rostasy","year":"2013","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.msard.2018.12.038_bib0026","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/rheumatology\/kei263","article-title":"Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment","volume":"45","author":"Falcini","year":"2006","journal-title":"Rheumatology"},{"issue":"UNSP e1881","key":"10.1016\/j.msard.2018.12.038_bib0027","article-title":"Rituximab monitoring and redosing in paediatric neuromyelitis optica spectrum disorder","volume":"3","author":"Nosadini","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818305662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818305662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:45:06Z","timestamp":1761900306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818305662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":27,"alternative-id":["S2211034818305662"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.12.038","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical course, treatment responses and outcomes in Chinese paediatric neuromyelitis optica spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}